[Use of coldact, a long-acting preparation of NATKO for the treatment of upper respiratory tract diseases in outpatient clinics].
Rumiantsev
A G
AG
Aldonina
V V
VV
Ilína
T P
TP
Snitsarenko
V Iu
VIu
Biriuchinskaia
I G
IG
Shevaldina
T V
TV
D000208:Acute Disease; D000328:Adult; D000553:Ambulatory Care; D002648:Child; D002744:Chlorpheniramine / Q000627:therapeutic use*; D003692:Delayed-Action Preparations / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D010665:Phenylpropanolamine / Q000627:therapeutic use*; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D016896:Treatment Outcome
D003692:Delayed-Action Preparations; D004338:Drug Combinations; C083542:chlorpheniramine, phenylpropanolamine drug combination; D010665:Phenylpropanolamine; D002744:Chlorpheniramine
Opyt primeneniia v poliklinicheskikh usloviiakh koldakta - preparata prolongirovannogo deĭstviia firmy NATKO dlia lecheniia zabolevaniĭ verkhnikh dykhatelńykh puteĭ.